On the one hand, anti-angiogenic drugs reverse VEGF-induced immunosuppression and normalize the tumor vasculature, which enhances the infiltration and perivascular accumulation of CD8+ CTLs expressing IFN-γ [127]. The gene discussed is CD8A; the disease is neoplasm.